STAT3 and breast carcinoma: STAT3 as well as STAT5 control the cytokine-induced expression of the cytoplasmic NADPH oxidase NOX2 [168], being e.g., crucial for DNA damage response in AML cells, leading together with mitochondrial ROS production, which is a predominant STAT3 affair to the production of ROS, responsible for MDSCs-induced immune suppression in murine colon, lung, mammary carcinoma, thymoma, sarcoma models and in patients with head and neck cancers [132].